Isolation and characterization of lytic Shigella bacteriophages with rapid in vitro and ex vivo bactericidal activity

Nida Shaheen1,2, Maranda Stricklin3, Martin Kordesch4

  • 1Department of Biomedical Sciences, Ohio University Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, United States.

Abstract

Insights

Newly isolated bacteriophages show potent activity against multidrug-resistant Shigella strains. These lytic phages demonstrate rapid bacterial killing in vitro and ex vivo, offering a promising alternative for treating Shigella infections.

Area of Science:

  • Microbiology
  • Bacteriophage Therapy
  • Antimicrobial Resistance

Background:

  • Shigellosis, caused by Shigella spp., is a global health threat.
  • Multidrug-resistant (MDR) Shigella strains necessitate novel therapeutic strategies.
  • Bacteriophages are explored as potential agents against MDR infections.

Purpose of the Study:

  • To isolate and characterize lytic bacteriophages targeting Shigella.
  • To evaluate the efficacy of these phages against Shigella in vitro and ex vivo.
  • To assess the potential of bacteriophages as a treatment for Shigella infections.

Main Methods:

  • Isolation of lytic bacteriophages from wastewater using the double-layer agar method.
  • Characterization of phage morphology, lytic spectrum, and growth kinetics (latent period, burst size).
  • Evaluation of bacterial killing efficiency and ex vivo efficacy in anaerobic fecal slurry co-cultures.

Main Results:

  • Ten lytic bacteriophages targeting Shigella flexneri were isolated.
  • Phages exhibited myovirus-like morphology and broad lytic activity against S. flexneri, S. sonnei, and S. dysenteriae.
  • Selected phages (PSW32, PSW40) demonstrated significant bacterial load reduction in ex vivo microbiota models, with PSW32 reducing CFUs by 88% within 2 hours.

Conclusions:

  • Newly isolated lytic phages show rapid and broad-spectrum activity against Shigella species.
  • Phages exhibit efficacy in both in vitro and ex vivo microbiota conditions.
  • These findings support the potential of bacteriophages for controlling Shigella infections and contamination.